Page results
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 28 January 2026.
-
In May 2020, UCLH invited acclaimed photographer Tom Pilston to take portraits of staff at the height of the Covid-19 pandemic.
-
The emergency department at University College Hospital is set to undergo an ambitious refurbishment project of the resuscitation (resus) area.
-
Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains, according to laboratory findings from UCLH and the Francis Crick Institute.
-
Information about travelling to your appointment for UCLH cancer services and different locations and hospitals.
-
Psychological guidance to help you prepare, cope, and recover.
-
A team of clinicians and researchers at UCLH and UCL have been awarded a £2.8 million grant to combat health inequalities in patients having major surgery.
-
Proton Beam Therapy (PBT) is a particularly effective form of radiotherapy used to treat certain types of cancers
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
File results
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0351 - Senior staff contact details for non-clinical workforce
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0341 - Senior staff contact details
-
FOI/2023/0340 - NHS charging of overseas visitors
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2020/0002 - Surgical tools left inside patients